It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
UPDATED 10:43 AM PT — Monday, March 16, 2020
Lawmakers from both sides of the aisle are teaming together in order to revitalize the U.S. drug manufacturing sector.
Sen. Marsha Blackburn (R-Tenn.) and Sen. Bob Menendez (D-N.J.) recently introduced the Securing America’s Medicine Cabinet (SAMC) Act to ramp up U.S. production of active pharmaceutical ingredients, or API’s. The pair believes the U.S. relies too heavily on foreign manufacturing of critical API’s, particularly in China.
“But right now, we depend heavily on Chinese and foreign companies to manufacture active pharmaceutical ingredients,” said Sen. Blackburn. “When this happens, we lose control of out supply.”
Urgency for passage of such a law follows the FDA’s announcement of a shortage of drugs to treat the coronavirus. The agency blamed difficulties in getting API’s from a Chinese manufacturing site.
originally posted by: 727Sky
This is one bill I hope gets done and signed into law as soon as possible. Globalization looks good for multinational corporations but self sufficiency seems to always work better for the people.
UPDATED 10:43 AM PT — Monday, March 16, 2020
Lawmakers from both sides of the aisle are teaming together in order to revitalize the U.S. drug manufacturing sector.
Sen. Marsha Blackburn (R-Tenn.) and Sen. Bob Menendez (D-N.J.) recently introduced the Securing America’s Medicine Cabinet (SAMC) Act to ramp up U.S. production of active pharmaceutical ingredients, or API’s. The pair believes the U.S. relies too heavily on foreign manufacturing of critical API’s, particularly in China.
“But right now, we depend heavily on Chinese and foreign companies to manufacture active pharmaceutical ingredients,” said Sen. Blackburn. “When this happens, we lose control of out supply.”
Urgency for passage of such a law follows the FDA’s announcement of a shortage of drugs to treat the coronavirus. The agency blamed difficulties in getting API’s from a Chinese manufacturing site.
www.oann.com...
originally posted by: AaarghZombies
a reply to: 727Sky
correct me if I'm wrong but didn't manufacturing go overseas due to the free market. It was cheaper to do it there, so companies went there.
How would Trump move production back to the US without leading to price raises.
We need something like the SAMC Act to enable us to have access to these drugs and these compounds that they are identifying we need,” Sen. Blackburn explained.
If passed, the SAMC Act would expand the FDA’s emergency technology program to tackle issues relating to national security and drug shortages. A $100 million grant would be provided to establish facilities to develop these pharmaceuticals and effectively train the industry’s workforce.
Blackburn and Menendez are optimistic their colleagues will adopt SAMC. The lawmakers noted that the Senate has been looking for a solution to the problem for years.
originally posted by: Arnie123
Blackburn and Menendez are optimistic their colleagues will adopt SAMC. The lawmakers noted that the Senate has been looking for a solution to the problem for years.
originally posted by: Stupidsecrets
Bring 25% of it back for good. Cost will go up but big picture, that's only one con. So what. I can think of 4-5 pros to counter that one devil's advocate point.
For one; jobs. For every dollar earned in the US by a US citizen, that dollar on average bounces around the economy 5-6 times. It's no longer bouncing around in China. Then we no longer have to rely on China. These will also likely be good jobs with benefits.